| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 6.92K | $49.5K | $7.16 | Sep 6, 2024 | Direct |
| Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 69K | May 29, 2024 | Direct | ||
| SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 10.5K | Jun 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SERA | SERA PROGNOSTICS, INC. | Sep 6, 2024 | 1 | -$687 | 4 | Sep 9, 2024 | Director |
| SERA | SERA PROGNOSTICS, INC. | Aug 7, 2024 | 1 | -$749 | 4 | Aug 8, 2024 | Director |
| SERA | SERA PROGNOSTICS, INC. | Jun 6, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| KPTI | Karyopharm Therapeutics Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
| SERA | SERA PROGNOSTICS, INC. | Jun 8, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
| KPTI | Karyopharm Therapeutics Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| SERA | SERA PROGNOSTICS, INC. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
| KPTI | Karyopharm Therapeutics Inc. | May 19, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| SERA | SERA PROGNOSTICS, INC. | Jul 14, 2021 | 0 | $0 | 3 | Jul 14, 2021 | Director |
| KPTI | Karyopharm Therapeutics Inc. | May 21, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |